Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy-Reference-Cited by-同舟云学术

Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy

Published:2024-04-09 Issue:8 Volume:67 Page:6854-6879
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lv Qi¹,Yang Hongqiong¹,Wang Dan¹,Zhou Haikun¹,Wang Juan¹,Zhang Yishu¹,Wu Dapeng²,Xie Ying¹,Lv Yingshan¹,Hu Lihong¹,Wang Junwei¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China

2. Jiangsu Provincial Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, P. R. China

Funder

Graduate Research and Innovation Projects of Jiangsu Province

Natural Science Foundation of Jiangsu Province

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00508

Reference42 articles.

1. Future therapeutic implications of new molecular mechanism of colorectal cancer

2. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

3. Colorectal cancer statistics, 2023

4. Diagnosis and Treatment of Metastatic Colorectal Cancer

5. Comprehensive review of targeted therapy for colorectal cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF-1R: A promising therapeutic target for various diseases;Pharmacological Research;2024-06